![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Bone density, microarchitecture and tissue quality after 48-weeks and 96-weeks of treatment with Tenofovir Disoproxil Fumarate.
|
|
|
Reported by Jules Levin
19th Intl Workshop on Co-morbidities and Adverse Drug reactions
Milan, Italy Oct 23-25 2017
Robert Guerri-Fernandez1 ,Todd T. Brown2, Ana Fernandez Marron1,Judit Villar 1, Alicia Gonzalez-Mena1 , Ana Guelar 1, Elisabet Lerma-Chipirraz1 , Hernando Knobel1, Adolfo Diez-Perez1
![1109171](../images/110917/110917-5/1109171.gif)
![1109172](../images/110917/110917-5/1109172.gif)
![1109173](../images/110917/110917-5/1109173.gif)
![1109174](../images/110917/110917-5/1109174.gif)
![1109175](../images/110917/110917-5/1109175.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|